跳至主要内容
临床试验/NCT03076463
NCT03076463已完成不适用

Long-term Effects of Grape Polyphenols as Modulators of Metabolic Syndrome in Humans

National Research Council, Spain2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2017年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
49
试验地点
2
主要终点
Fasting insulin

研究概览

简要总结

The aim of this is study is to evaluate the long-term effects of grape polyphenols in the modulation of markers of metabolic syndrome. Most of the previous works about polyphenols have only considered a fraction of polyphenols, i.e., extractable polyphenols. As a consequence, an important amount of dietary polyphenols, the so-called non-extractable polyphenols are ignored. In contrast, the effect of both extractable and non-extractable polyphenols will be considered in this study. Also, studies on the long-term effect of grape polyphenol on markers of metabolic syndrome have been mostly conducted in animals, so clinical trials on this topic are needed.

详细描述

Fifty supposedly healthy volunteers with at least two cardiometabolic risk factors were recruited. The cardiometabolic risk factors used to select the subjects are described below.

The whole intervention will be divided in 2 periods, control (CTR) and dried and milled grape pomace (GRAPOM). The two periods will have a duration of 6 weeks. During the CTR period, subjects will follow their normal dietary habits and samples will be collected at the beginning and at the end. No proper placebo could be found for the product, so this CTR period was chosen. During the GRAPOM period, the subjects will daily consume 8 g of the product solved in water and samples will be collected at the beginning and at the end.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least two of the following requirements:
  • BMI ≥ 25 kg/m
  • Fasting glucose values ≥ 100 mg/dL.
  • Triglycerides ≥ 150 mg/dL.
  • HDL-cholesterol: ≤ 50 mg/dL women, ≤ 40 mg/dL men.
  • Blood pressure: systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg.

排除标准

  • Subjects with a pharmaceutical treatment set to modify blood pressure, lipid profile or glucose.
  • Volunteers participating in other studies or weight loss plans.
  • Pregnant or breastfeeding women.

结局指标

主要结局

Fasting insulin

时间窗: Up to three months

Changes of blood insulin fasting levels as result of long-term supplementation with grape pomace (GRAPOM).

Fasting glucose

时间窗: Up to three months

Changes of blood glucose fasting levels as result of long-term supplementation with grape pomace (GRAPOM).

次要结局

  • Postprandial insulin(Up to four months)
  • Postprandial glucose(Up to four months)
  • Blood pressure(Up to four months)
  • Blood C reactive protein(Up to five months)
  • Blood fibrinogen(Up to five months)
  • Blood cholesterol (total, HDL, LDL)(Up to four months)
  • Blood triglycerides(Up to four months)
  • Iron metabolism(Up to six months)
  • miRNA expression(Up to eight months)
  • Blood uric acid(Up to five months)
  • Profile of fecal microbiota(Up to nine months)
  • Blood polyphenols(Up to six months)
  • Urine polyphenols(Up to seen months)
  • Body fat(Up to seven months)
  • Urine uric acid(Up to six months)
  • Body weight(Up to three months)

研究者

发起方
National Research Council, Spain
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jara Pérez-Jiménez

PhD

National Research Council, Spain

研究点 (2)

Loading locations...

相似试验